| ID | 1657 | |
| PMID | 11062537 | |
| Year | 2000 | |
| Sequence | Aa-MeLeu-MeLeu-MeVal- 3-hydroxy-N,4-dimethyl-L-2-amino- 6-octenoyl-Abu-MeGly-MeLeu-V-MeLeu | |
| Name | Cyclosporine | |
| Length | 11 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Cyclic (head to tail) | |
| Chirality | Mix | |
| Chemical Modification | Abu= amino butyric acid, MeLeu=N-methyl-Leucine, MeVal=N-methyl-Valine | |
| Origin of Peptide | Synthetic | |
| Nature of Peptide/Cargo | Not mentioned | |
| Mechanism | Not mentioned | |
| Cargo Sequence/Structure | No cargo | |
| Name of cargo | Not applicable | |
| Assay | Dual-color fluorescence microscopy. | |
| Enhancer | 1-mM solution of biotinylated hepta-D-arginine (biotin r7) dissolved in PBS with an equal volume of lotion vehicle. | |
| Properties of enhancer | Not mentioned | |
| Concentration | 1% releasable R7–CsA conjugate | |
| Incubation time | 1 night | |
| Tissue permeability (value with units) | The inflammation was healed in the treated ear. | |
| Tissue Sample | mouse and human skin | |
| Ex vivo/In vivo/In vitro | in vitro | |
| STRUCTURE |
| |
| SMILES | N.A. | |